Evidence map›Paper›PMID 34928493›Full record

ArticleInfection2022

Individualizing the use of [

Eline J van Leerdam, Michelle Gompelman, Renée A M Tuinte, Erik H J G Aarntzen, Marvin A H Berrevoets, Ianthe Maat, Chantal P Bleeker-Rovers, Reinout van Crevel, Jaap Ten Oever, Ilse J E Kouijzer

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Validation of a new risk stratification system-based management for methicillin-resistant Staphylococcus aureus bacteraemia: analysis of a multicentre prospective study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  5. Article
  6. Review
  7. [Frontiers in medicine · 2023
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Eline J van LeerdamDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Michelle GompelmanDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Renée A M TuinteDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Erik H J G AarntzenDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands.
Marvin A H BerrevoetsDepartment of Internal Medicine, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Ianthe MaatDepartment of Medical Microbiology and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
Chantal P Bleeker-RoversDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Reinout van CrevelDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Jaap Ten OeverDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
Ilse J E KouijzerDepartment of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Ilse.Kouijzer@radboudumc.nl.
Radboud University Nijmegen · NLRadboud University Medical Center · NLElisabeth-TweeSteden Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose[

methodsIn a retrospective single-center cohort study, we included all consecutive adult patients with SAB between 2013 and 2020 if an [

resultsAmong 132 patients included, the original treatment plan was changed after [

conclusion[

Indexed as

BacteremiaFluorodeoxyglucose F18AdultCohort StudiesHumansPositron Emission Tomography Computed TomographyRetrospective StudiesStaphylococcus aureusTertiary Care CentersFluorodeoxyglucose F18[18F]FDG-PET/CTMetastatic infectionProlonged treatmentStaphylococcus aureus bacteremia

Identifiers

PMID34928493
PMCPMC8942890
OpenAlexW4200084093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.